Page last updated: 2024-10-24

celecoxib and Neoplasms, Bone Marrow

celecoxib has been researched along with Neoplasms, Bone Marrow in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Herein we analyzed the effect of cyclooxygenase-2 (COX-2) inhibitor celecoxib in a model of generalized BM dissemination of left cardiac ventricle-injected B16 melanoma (B16M) cells into healthy and bacterial endotoxin lipopolysaccharide (LPS)-pretreated mice to induce inflammation."3.77Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2. ( Carrascal, T; Crende, O; Hernández, JJ; Mendoza, L; Salado, C; Valcárcel, M; Vidal-Vanaclocha, F, 2011)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valcárcel, M1
Mendoza, L1
Hernández, JJ1
Carrascal, T1
Salado, C1
Crende, O1
Vidal-Vanaclocha, F1

Other Studies

1 other study available for celecoxib and Neoplasms, Bone Marrow

ArticleYear
Vascular endothelial growth factor regulates melanoma cell adhesion and growth in the bone marrow microenvironment via tumor cyclooxygenase-2.
    Journal of translational medicine, 2011, Aug-25, Volume: 9

    Topics: Animals; Blotting, Western; Bone Marrow; Bone Marrow Neoplasms; Celecoxib; Cell Adhesion; Cell Line,

2011